JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | 0.0% | 562 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 562 | -14.8% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 660 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -20.0% | 660 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 660 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +25.0% | 660 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -42.9% | 660 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | +40.0% | 660 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | -44.4% | 660 | -43.1% | 0.00% | – |
| Q3 2020 | $9,000 | +200.0% | 1,160 | +132.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $63,428,000 | 41.36% |
| TRV GP III, LLC | 3,048,780 | $18,902,000 | 9.26% |
| Omega Fund Management, LLC | 1,059,930 | $6,572,000 | 1.39% |
| Alambic Investment Management, L.P. | 50,622 | $314,000 | 0.13% |
| Spark Investment Management LLC | 244,300 | $1,514,000 | 0.07% |
| ALGERT GLOBAL LLC | 14,182 | $88,000 | 0.05% |
| Redmile Group, LLC | 254,590 | $1,578,000 | 0.05% |
| Granahan Investment Management | 125,533 | $778,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 38,602 | $239,000 | 0.02% |
| Frontier Wealth Management LLC | 27,099 | $168,000 | 0.02% |